XPhyto Therapeutics (XPHY.C), with its partner and acquisition target, 3a-diagnostics GmbH announced today that it has successfully registered its first biosensor test in oral inflammation with the German authorities….
Robertson
Cancer is a bitch. Even if you haven’t had to battle against cancer yourself, you likely know someone who has. Unfortunately for me, that person was my mom; however,…
Chembio Diagnostics (CEMI.Q) today announced its launch of commercial distribution of an FDA Emergency Use Authorized, patent pending, rapid point-of-care COVID-19 antigen test for use in decentralized and traditional…
Week in Review My week was great, thanks for asking. In fact, I went on my first date since COVID-19 turned the world upside down. We made reservations for…
Ozop Energy Solutions (OZSC.OTC) announced today that its wholly owned subsidiary, Ozop Energy Systems, Inc. has executed a purchase order for a Tesla Megapack® for their first of more…
Aditxt Inc. (ADTX.Q) announced today that it has signed a letter of intent (LOI) to acquire a biopharmaceutical company commercializing COVID-19 antiviral oral therapy. The target company is currently…
Victory Square Technologies (VST.C) announced today that its portfolio company Turnium Technology Group is collaborating with IBM to onboard its cloud-native SD-WAN edge solution to IBM Cloud for Telecommunications….
PolarityTE (PTE.Q) has provided an update regarding correspondence from the U.S. Food and Drug Administration (FDA) related to the Company’s Investigational New Drug Application (IND) for SkinTE®, which was…
Tonix Pharmaceuticals (TNXP.Q) announced today that it has received the official minutes from a Type B pre-Investigational New Drug (IND) meeting with the U.S. Food and Drug Administration (FDA)…
Vivos Therapeutics (VVOS.Q) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) market clearance to Vivos’ mmRNA (modified mandibular Repositioning Nighttime Appliance) device, not to be…